Sucampo Pharmaceuticals Company Profile (NASDAQ:SCMP)

Analyst Ratings

Consensus Ratings for Sucampo Pharmaceuticals (NASDAQ:SCMP) (?)
Ratings Breakdown: 2 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $21.88 (92.39% upside)

Analysts' Ratings History for Sucampo Pharmaceuticals (NASDAQ:SCMP)
Show:
DateFirmActionRatingPrice TargetActions
7/12/2016Roth CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/11/2016MizuhoReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/11/2016Maxim GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016WallachBeth CapitalUpgradeHold -> Buy$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016GuggenheimReiterated RatingBuy$29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2016Leerink SwannReiterated RatingMarket Perform$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/9/2016Jefferies GroupLower Price TargetHold$19.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2015HC WainwrightLower Price Target$36.00 -> $28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2015Cantor FitzgeraldDowngradeBuy -> Hold$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/2/2015Credit Suisse Group AGDowngradeNeutral -> Underperform$10.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/26/2014 forward)

Earnings

Earnings History for Sucampo Pharmaceuticals (NASDAQ:SCMP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/3/2016ListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/4/2016Q116$0.19$0.21$44.11 million$47.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/8/2016Q415$0.19$0.43$42.72 million$55.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2015Q315$0.18$0.16$36.18 million$33.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2015Q215$0.15$0.21$31.90 million$34.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015Q114$0.14$0.14$30.19 million$29.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/4/2015Q413$0.17$0.21$37.23 million$37.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2014Q313$0.04$0.03$26.11 million$31.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2014Q213$0.03$0.04$24.06 million$24.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2014Q113$0.04$0.02$24.19 million$22.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2014Q4($0.04)$0.06$22.75 million$24.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/13/2013Q4 2012$0.12$0.32$32.21 million$34.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Sucampo Pharmaceuticals (NASDAQ:SCMP)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$0.19$0.26$0.21
Q2 20165$0.20$0.29$0.25
Q3 20164$0.26$0.32$0.29
Q4 20164$0.35$0.38$0.36
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Sucampo Pharmaceuticals (NASDAQ:SCMP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Sucampo Pharmaceuticals (NASDAQ:SCMP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
8/28/2015Daniel P. GetmanDirectorSell30,000$28.14$844,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/20/2015Thomas J KnappInsiderSell64,528$23.43$1,511,891.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/12/2015William AshtonDirectorSell55,762$17.55$978,623.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2015Anthony C CelesteDirectorSell65,966$17.34$1,143,850.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2014Cary J ClaiborneCFOSell50,000$12.91$645,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2014Cary J ClaiborneCFOSell7,100$12.89$91,519.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2014Sachiko KunoMajor ShareholderSell181,727$6.28$1,141,245.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/4/2014Ryuji UenoMajor ShareholderSell140,873$6.02$848,055.46View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/31/2014S&R Technology Holdings, LlcMajor ShareholderSell100$6.25$625.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/30/2014S&R Technology Holdings, LlcMajor ShareholderSell300$6.25$1,875.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/25/2014Ryuji UenoMajor ShareholderSell16,155$6.26$101,130.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/23/2014Ryuji UenoMajor ShareholderSell5,845$6.29$36,765.05View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/22/2014S&R Technology Holdings, LlcMajor ShareholderSell2,500$6.25$15,625.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/21/2014S&R Technology Holdings, LlcMajor ShareholderSell100$6.25$625.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/18/2014S&R Technology Holdings, LlcMajor ShareholderSell15,000$6.27$94,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2014S&R Technology Holdings, Llcmajor shareholderSell113,600$6.65$755,440.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/25/2014Sachiko Kunomajor shareholderSell118,700$6.69$794,103.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2014Gayle DolecekDirectorSell1,200$8.03$9,636.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/27/2014Cary ClaiborneCFOSell2,500$9.00$22,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/17/2014Ryuji UenoCEOSell360,000$10.36$3,729,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/7/2014Cary ClaiborneCFOSell2,500$9.00$22,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/16/2013Sachiko KunoMajor ShareholderSell360,000$6.35$2,286,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/18/2013Ryuji UenoCEOSell38,462$5.69$218,848.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2013Ryuji UenoCEOSell38,462$5.59$215,002.58View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2013Ryuji UenoCEOSell38,462$6.04$232,310.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/6/2013Sachiko Kunomajor shareholderSell38,462$6.21$238,849.02View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/24/2013Ryuji UenoCEOSell38,462$6.52$250,772.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/9/2013S&R Technology Holdings, LlcMajor ShareholderSell38,462$6.48$249,233.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/24/2013S&R Technology Holdings, LlcMajor ShareholderSell38,462$6.61$254,233.82View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2013Sachiko KunoMajor ShareholderSell38,462$7.29$280,387.98View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2013Ryuji UenoCEOSell38,462$8.79$338,080.98View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/21/2013Cary J ClaiborneCFOSell4,640$9.52$44,172.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2013Stanley G MieleSVPSell6,400$9.60$61,440.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2013Stanley G MieleSVPSell48,600$9.67$469,962.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2013Timothy I MaudlinDirectorBuy32,870$9.82$322,783.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2013Sachiko KunoMajor ShareholderSell38,462$9.27$356,542.74View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2013S&R Technology Holdings, LlcMajor ShareholderSell38,462$5.22$200,771.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/26/2012S&R Technology Holdings, LlcMajor ShareholderSell20,262$5.01$101,512.62View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/27/2012Sachiko KunoMajor ShareholderSell12,205$5.00$61,025.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2012Sachiko KunoMajor ShareholderSell11,962$5.00$59,810.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/1/2012Sachiko KunoMajor ShareholderSell37,595$5.06$190,230.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Sucampo Pharmaceuticals (NASDAQ:SCMP)
DateHeadline
07/22/16 06:05 PMHow Analysts Rated Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Last Week? - Press Telegraph
07/21/16 06:39 PMSucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Expected To Post Sales Of $371.307 - Investor Newswire
07/21/16 06:39 PMSucampo Pharmaceuticals, Inc. (NASDAQ:SCMP): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/21/16 06:39 PMSucampo Pharmaceuticals Inc Realized Volatility Hits A Lowered Level - CML News
07/21/16 06:39 PMWill Investors Find Any Relief with Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) - TGP
07/21/16 06:39 PMSucampo Pharmaceuticals Inc. (SCMP) Jumps 5.26% on July 20 - Equities.com
07/20/16 07:13 PMSucampo Pharmaceuticals Inc. (SCMP) Jumps 5.26% on July 20
07/20/16 05:45 AMSucampo Announces Second Quarter 2016 Earnings Call - [GlobeNewswire] - ROCKVILLE, Md., July 20, 2016-- Sucampo Pharmaceuticals, Inc., a global biopharmaceutical company, today announced that it will host its second quarter 2016 financial results teleconference and webcast ...
07/19/16 12:30 PMThis Impressive Small-Cap Pharma Is Set For Its Next Big Move -
07/19/16 07:25 AMNew Broker Ratings For Sucampo Pharmaceuticals, Inc. (SCMP) - FTSE News
07/18/16 11:53 AMShares Moving Down on the Week: Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) - Engelwood Daily
07/18/16 11:53 AMStrong Sell Calls For Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) At 0 - Investor Newswire
07/18/16 11:53 AMShare Performance Summary for: Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) - Press Telegraph
07/18/16 11:53 AMSucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Wall Street Analyst Recommendation Outlook - TGP
07/18/16 07:24 AMSucampo Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SCMP-US : July 18, 2016 -
07/14/16 09:55 AMSucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/12/16 06:34 PMSucampo to Stop Developing Cobiprostone for Oral Mucositis
07/12/16 05:31 AMSUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -
07/11/16 06:14 PMWall Street Ratings and Target Price Views on Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) - Telanagana Press
07/11/16 06:14 PMIs $29 Within Reach For Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP)? - Investor Newswire
07/11/16 06:14 PMSucampo Pharma (SCMP) to Discontinue Cobiprostone Development Following Phase 2a Results - StreetInsider.com
07/11/16 09:34 AMSUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K/A, Financial Statements and Exhibits -
07/11/16 07:22 AMBRIEF-Sucampo Pharmaceuticals updates on Cobiprostone Development Program - * Sucampo provides update on Cobiprostone Development Program Source text for Eikon: Further company coverage:
07/11/16 06:43 AMSucampo Provides Update on Cobiprostone Development Program - [at noodls] - Click here to print ROCKVILLE, Md., July 11, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced the decision to discontinue ...
07/08/16 06:17 PMBroker Outlook For Sucampo Pharmaceuticals, Inc. (SCMP) - Fiscal Standard
07/08/16 03:02 PMSucampo Pharmaceuticals Announces Webcast of Its Presentation at Cantor Fitzgerald’s 2nd Annual Healthcare Conference - [GlobeNewswire] - ROCKVILLE, Md., July 08, 2016-- Sucampo Pharmaceuticals, Inc., a global biopharmaceutical company, today announced that it will webcast its corporate presentation at Cantor Fitzgerald’ s 2 nd Annual Healthcare ...
07/07/16 07:11 AMSucampo Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SCMP-US : July 7, 2016 -
07/04/16 10:52 AMStock Valuation in Review: Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) - Telanagana Press
06/30/16 06:36 PMSucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Earnings Glance and Target Price Review - Engelwood Daily
06/28/16 06:11 PMCovering the Bases on Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP): Where is the Stock Going? - Press Telegraph
06/28/16 06:11 PMSucampo Pharmaceuticals, Inc. (SCMP) Updated Price Targets - FTSE News
06/28/16 03:11 PMSUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets, Financial Sta -
06/27/16 10:27 AMStrong Sell Calls Recommendations For Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) At 0 - Investor Newswire
06/27/16 10:27 AMSucampo Pharmaceuticals, Inc. (SCMP) Broker Price Targets For The Coming Week - Fiscal Standard
06/25/16 10:01 AMBrokers Issue Average Price Target Of 19.38 On Sucampo Pharmaceuticals, Inc. (SCMP) - Fiscal Standard
06/23/16 08:55 AMSucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Yearly Sales Projections At $371.307 - Investor Newswire
06/20/16 05:58 PMStrong Buy Calls Count For Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) At 5 - Investor Newswire
06/20/16 05:58 PMThis Weeks Broker Views For Sucampo Pharmaceuticals, Inc. (SCMP) - Fiscal Standard
06/20/16 02:47 PMSucampo Pharmaceuticals, Inc. – Value Analysis (NASDAQ:SCMP) : June 20, 2016 -
06/15/16 06:13 PMSucampo Pharmaceuticals Inc. (SCMP) Drops 7.44% on June 13 - Equities.com
06/15/16 10:49 AMSucampo Pharmaceuticals Inc. (SCMP) Drops 7.44% on June 13
06/14/16 07:48 AMSucampo Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SCMP-US : June 14, 2016 -
06/12/16 06:17 PMTrend Of Rating Given To Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) - Investor Newswire
06/08/16 06:48 PMSUCAMPO PHARMACEUTICALS INC. (NASDAQ:SCMP) Financial Condition Compared to S&P 500 - CML News
06/08/16 03:20 PMSUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/07/16 09:04 AMUpcoming Earnings Report: Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) - iStreetWire
06/05/16 08:58 AMSucampo Pharmaceuticals' (SCMP) “Buy” Rating Reaffirmed at Mizuho - Let Me Know About This
06/04/16 09:17 AMAnalysts Observing Stocks: Masimo Corporation (NASDAQ:MASI) , Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) - Street Updates
06/02/16 09:24 AMStock Review and Earnings Check on Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) - HNN - Stock Review and Earnings Check on Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP)HNNCompany earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) to report quarterly EPS of $0.22. The company's next earnings report is expected to be ...and more »
06/01/16 09:14 AMSucampo Pharmaceuticals Inc. (SCMP) Jumps 5.7% on May 30 - Equities.com - Sucampo Pharmaceuticals Inc. (SCMP) Jumps 5.7% on May 30Equities.comSucampo Pharmaceuticals Inc. (SCMP) was among the biggest gainers on the Russell 2000 for Monday May 30 as the stock popped 5.7% to $12.42, representing a gain of $0.67 per share. Some 491,236 shares traded hands on 3,463 trades, compared with ...Recently Changed Price Targets On Sucampo Pharmaceuticals, Inc. (SCMP)Risers & FallersSucampo Pharmaceuticals, Inc. (NASDAQ:SCMP)'s Company Shares Increased 15.21% After High VolatilityThe PostWeak On High Volume: Sucampo Pharmaceuticals (SCMP)TheStreet.comEIN News (press release)all 5 news articles »

Social

About Sucampo Pharmaceuticals

Sucampo Pharmaceuticals logoSucampo Pharmaceuticals, Inc. is a global biopharmaceutical company. The Company focuses on research and development of drugs to treat gastrointestinal, ophthalmic, and oncology-based inflammatory disorders. It generates revenue from product royalties, development milestone payments, product sales and clinical development activities. Its operations are conducted through Sucampo AG (SAG), based in Zug, Switzerland, through which the Company conducts certain worldwide and European operations; Sucampo Pharma, LLC, based in Tokyo and Osaka, Japan, through which the Company conducts its Asian operations; Sucampo Pharma Americas LLC, based in Bethesda, through which the Company conducts operations in North and South America, and Sucampo Pharma Europe, Ltd., based in Oxford, United Kingdom. The Company's geographic segments are Asia, the Americas and Europe.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: SCMP
  • CUSIP: 86490910
Key Metrics:
  • Previous Close: $11.37
  • 50 Day Moving Average: $11.20
  • 200 Day Moving Average: $11.80
  • P/E Ratio: 22.51
  • P/E Growth: 0.84
  • Market Cap: $484.70M
  • Beta: 1.41
  • Current Year EPS Consensus Estimate: $1.01 EPS
  • Next Year EPS Consensus Estimate: $1.30 EPS
Additional Links:
Sucampo Pharmaceuticals (NASDAQ:SCMP) Chart for Tuesday, July, 26, 2016